Cargando…
Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China
BACKGROUND: Lamivudine (LMV), as the preferred oral drug for use in treatment of HBV, always results in development of resistance mutations after long-term treatment. In this study we investigated chronic hepatitis B (CHB) patients in southern China to determine whether different HBV genotypes affec...
Autores principales: | Li, Si-Yue, Qin, Li, Zhang, Lei, Song, Xing-Bo, Zhou, Yi, Zhou, Juan, Lu, Xiao-Jun, Cao, Ju, Wang, Lan-Lan, Wang, Jun, Ying, Bin-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539467/ https://www.ncbi.nlm.nih.gov/pubmed/21959623 http://dx.doi.org/10.12659/MSM.881965 |
Ejemplares similares
-
HBV Genotype B/C and Response to Lamivudine Therapy: A Systematic Review
por: Chen, Xiu-Li, et al.
Publicado: (2013) -
Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015) -
Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province
por: Wang, Yin, et al.
Publicado: (2023) -
Early and Subsequent Epidemic Characteristics of COVID-19 and Their Impact on the Epidemic Size in Ethiopia
por: Amhare, Abebe Feyissa, et al.
Publicado: (2022) -
Lamivudine treatment for severe acute HBV hepatitis
por: Lisotti, Andrea, et al.
Publicado: (2008)